Eyenovia, Inc. (EYEN): Price and Financial Metrics
EYEN Price/Volume Stats
| Current price | $2.97 | 52-week high | $124.80 |
| Prev. close | $2.44 | 52-week low | $0.85 |
| Day low | $2.11 | Volume | 1,208,100 |
| Day high | $3.17 | Avg. volume | 1,558,124 |
| 50-day MA | $1.61 | Dividend yield | N/A |
| 200-day MA | $13.84 | Market Cap | 8.56M |
EYEN Stock Price Chart Interactive Chart >
Eyenovia, Inc. (EYEN) Company Bio
Eyenovia, Inc., a clinical stage biopharmaceutical company, engages in developing a pipeline of ophthalmology products in the United States. It is developing MicroProst that has completed Phase III clinical trials for the treatment of chronic angle closure glaucoma; MicroStat that has completed Phase II clinical trials for the treatment of mydriasis; MicroTears for the treatment of dry eye; and MicroPine for the treatment of myopia. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was founded in 2014 and is based in New York, New York.
EYEN Price Returns
| 1-mo | 162.83% |
| 3-mo | 77.84% |
| 6-mo | -58.75% |
| 1-year | -94.21% |
| 3-year | -97.83% |
| 5-year | -98.85% |
| YTD | -74.57% |
| 2024 | -92.98% |
| 2023 | 27.61% |
| 2022 | -59.25% |
| 2021 | -33.99% |
| 2020 | 35.27% |
Loading social stream, please wait...